N-ASSAY CPK-L— 510(k) K980900

Substantially Equivalent

Crestat Diagnostics, Inc.

FDA 510(k) clearance K980900 for N-ASSAY CPK-L, Substantially Equivalent on 1998-03-26. Applicant: Crestat Diagnostics, Inc..

Clearance details

Applicant: Crestat Diagnostics, Inc.
Product code: Code CGS
Advisory panel: Clinical Chemistry
Date received: 1998-03-10
Decision date: 1998-03-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Seattle, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.